Dr. Bhardwaj

Dr. Nina Bhardwaj, MD, PhD, is the Director of Immunotherapy and the Medical Director of the Vaccine and Cell Therapy Core facility. She is an expert on human dendritic cell (DC) subsets, specifically with respect to their isolation, biology, function and use as vaccine adjuvants in humans. She has been principal investigator for the design and implementation of several clinical trials studying novel experimental immunotherapies, including neoantigen vaccines, for melanoma and other cancers using TLR agonists including poly IC:LC or dendritic cells as adjuvants, and in combination with checkpoint inhibitors. Her lab also investigates DC and T cell biology in the tumor micro-environment as it relates to anti-cancer immunity.


1981                      Immunology Award, NYU School of Medicine

1984 – 1987          Irvington House Fellowship

1991 – 1995          Irma T. Hirschl Career Scientist Award

1995 – 1996          New York Community Trust Award

1999                      American Society of Clinical Investigation, Elected member

1999 – 2003         NIH Study Section Member: AIDS and Related Research 2

1999 – 2004         Burroughs Welcome Clinical Scientist Award

2001 – 2006         Elizabeth Glaser Scientist Award

2001                     Alpha Omega Alpha Almuna Award

2002                     Ann Belsky Moraines Visiting Professorship & Lectureship Award, NYU

2002 – 2007        Doris Duke Distinguished Clinical Scientist Award

2004                     Merit Award, NIH

2004                     Scientific American Top 50 Researchers Award (Medical Research)

2005 – 2006        Empire Who’s Who Honored Member

2008 – 2013        NIAID: Vaccine Research Center Board of Scientific Counselors

2009                     American Association of Physicians, Elected member

2009 – 2011         American Recovery & Reinvestment Act

2010                     Henry Silverman/Melanoma Research Alliance Team Science Award

2012                     New York University, Solomon A. Berson Award in Basic Science

2013 – Present    Ward Coleman Chair in Cancer Research

2015                    Frederick W. Alt Award for New Discoveries in Immunology, CRI



Department of Medicine

Division of Hematology and Medical Oncology

Tisch Cancer Institute

Vaccine and Cell Therapy Laboratory